

Publisher: John Wiley & Sons Inc
E-ISSN: 1744-3091|62|1|67-69
ISSN: 1744-3091
Source: Acta Crystallographica Section F, Vol.62, Iss.1, 2006-01, pp. : 67-69
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Human phosphate‐binding protein (HPBP) was serendipitously discovered by crystallization and X‐ray crystallography. HPBP belongs to a eukaryotic protein family named DING that is systematically absent from the genomic database. This apoprotein of 38 kDa copurifies with the HDL‐associated apoprotein paraoxonase (PON1) and binds inorganic phosphate. HPBP is the first identified transporter capable of binding phosphate ions in human plasma. Thus, it may be regarded as a predictor of phosphate‐related diseases such as atherosclerosis. In addition, HPBP may be a potential therapeutic protein for the treatment of such diseases. Here, the purification, detergent‐exchange protocol and crystallization conditions that led to the discovery of HPBP are reported.